Background: Severe pulmonary hypertension (PH) contributes to significant morbidity and mortality and may increase the number of complications and death in heart surgery. Objective: To evaluate the impact of PH on surgical mortality and three-year survival after aortic valve replacement surgery. Methods: Retrospective cohort study of patients undergoing aortic valve replacement surgery from May 2011 to December 2012 at Instituto Nacional de Cardiologia, RJ. The study population was stratified into two groups according to the systolic pulmonary artery pressure (SPAP): <45 mmHg and ≥45 mmHg. The chi-square test was used for comparison between groups; surgical mortality was studied by logistic regression and survival by Kaplan-Meier method and log-rank test; the hazard ratio was examined using the Cox method. Results: The study included 182 patients, 57.0% were males aged 61.0±13.0 years, with systemic arterial hypertension (72.0%), diabetes mellitus (22.0%), functional class by the New York Heart Association III/IV (61.1%), SPAP ≥45 mmHg (14.3%). Overall mortality rate was 12.0%. Survival rate was higher in the group with SPAP <45 mmHg -89.0% at one year and 86.0% at three year compared with the group with SPAP ≥45 mmHg -68.8% at one year and 58.1% (35.1% to 75.4%) at three years (p=0.0004). Conclusion: Patients with SPAP ≥45 mmHg had higher surgical mortality and worse survival at three years after aortic valve replacement surgery.
Introduction
Pulmonary hypertension (PH) secondary to left heart disease corresponds to group 2 in the Dana Point 1 classification and this group is currently considered the most prevalent one. The last update of this classification considers the following diseases: left ventricular systolic and diastolic dysfunction, valve diseases and congenital heart diseases 2 . The PH pathophysiology in this context is complex and it is believed that increased left atrial pressure is retrogressively transmitted to the pulmonary vessels to trigger adaptation processes of endothelial cells 3 .
In valve diseases, the prevalence of PH is related to the severity of valve involvement and associated symptoms and is present in about 65% of patients with severe aortic stenosis 4 . When present, PH adds greater morbidity and mortality to these individuals 5, 6 . Besides this, it is considered an important prognostic variable in patients with valvulopathy expecting surgery and is associated with complications and death 7 .
In Brazil, despite the limited data about cardiac surgery in the public health system (Brazilian National Health System -SUS), rheumatic disease is responsible for most indications of valve replacement, 8, 9 and for the large number of individuals with chronic rheumatic disease receiving clinical treatment 10 . In fact, a recent publication showed that the most common etiologies for valve dysfunction in 491 patients undergoing heart valve surgery were rheumatic disease (60.3%), degenerative valve disease (15.3%) and e n d o c a r d i t i s ( 4 . 5 % ) 1 1 . Pulmonary hypertension is part of the delayed progression of valve disease and, in developing countries, there are no studies on the impact of PH on survival, even after the valve replacement surgery. In patients with aortic valve disease, knowledge of data can have great relevance in clinical practice, since recent guidelines do not consider PH for surgery indication 12, 13 . Therefore, the purpose of this study was to analyze the impact of PH on surgical mortality and three-year survival after aortic valve replacement surgery.
Methods
This is a cohort retrospective study held at the INC, which included a review of the records of medical records of patients consecutively admitted between May 2011 and December 2012, undergoing cardiac aortic valve replacement surgery, indicated according to the national 14 and international 15 p=0.010) were independent risk factors of hospital mortality.
The bivariate Cox survival analysis stratified by the SPAP level demonstrated an association with outcome for the following variables: age, left atrial diameter indexed to the body surface area (LA/BSA), creatinine clearance (each 5 mL) and NYHA functional class IV and SPAP (Table 3) .
Cox multivariate analysis showed the following independent predictors of survival: age, LA/BSA ratio, NYHA functional class IV and SPAP ( LA/BSA -left atrial diameter by body surface area; NYHA IV -New York Heart Association functional class IV; SPAP -systolic pulmonary artery pressure
Discussion
PH is a frequent finding 16 in candidates for aortic valve replacement surgery and may reflect the degree of valve lesion. In this study, 56 (30.0%) patients had SPAP ≥30 mmHg and 14.3% were in the SPAP ≥45 mmHg group. Postoperative mortality was higher in individuals with higher SPAP value with a relative risk of 33.5%. Higher SPAP values were also associated with a greater number of tricuspid valve procedures and a lower proportion of patients requiring amines for less than 24 hours and mechanical ventilation for less than 12 hours.
The moderate/severe PH group also had a lower threeyear survival rate. It is believed that increased SPAP levels are a result of passive transmission of high left ventricular (LV) and left atrial (LA) end-diastolic filling pressures to the pulmonary arteries, indicating the presence of ventricular dysfunction 17 . As expected, patients in the higher SPAP group presented a higher prevalence of NYHA functional class IV and higher systolic and diastolic LV and LA end diameters ratios by SC, as well as lower LV ejection fraction values. Given the high prevalence of rheumatic fever in Brazil, rheumatic etiology contributed to 1/4 of cases of valve replacement.
High levels of SPAP are a known risk factor for morbidity and mortality in cardiac surgery 18 . However, in the context of aortic valve replacement, the impact PH still seems controversial. Johnson et al. 19 found no significant difference in hospital mortality and follow-up of patients with aortic stenosis stratified by SPAP. Tracy et al.
20 also found no difference in mortality in a small sample stratified by SPAP.
Recent retrospective cohort showed that preoperative PH did not affect survival in the follow-up of population and mortality was similar between the mild/moderate and severe SPAP groups; but the study did not compare outcomes between patients with and without PH 21 . In contrast, more recent retrospective cohorts with a larger number of participants have demonstrated the impact of PH not only on surgical mortality but also on patient survival. A study published in 2013 with 1 116 patients 7 found an association between high levels of SPAP and higher surgical mortality and worse survival in mean follow-up time of 2.5 years. Higher SPAP groups also presented higher number of in-hospital complications such as vasoactive amines and mechanical ventilation for longer periods, more infectious complications and longer hospital stay. Melby et al. 22 observed, in 1080 patients with severe aortic stenosis undergoing valve replacement surgery, mortality of 9.4% in those with PH, while in the group without PH this rate was 5.4% (p=0.018). In the same population, the five-year survival rate was significantly lower in groups with higher SPAP.
Analysis of SPAP values after valve replacement surgery showed worse survival for patients with PH (45.0% vs. 78.0%; p<0.001). Miceli et al. 23 and Zuern et al. 24 found, in a sample of 422 and 200 patients, respectively, with severe aortic stenosis, results similar to those mentioned above. In the cohort of Miceli et al. 23 , the five-year survival rate for the normal SPAP group was 86.0%, in contrast to the groups of mild/moderate PH and severe PH, with 81.0% and 63.0%, respectively (p<0.001).
The most important study in a population with aortic regurgitation and PH is probably the one published by Khandhar et al. 25 . Of the 506 patients studied, 16.4% had PH ≥60 mmHg. Of these, 32 underwent aortic valve replacement surgery and a higher five-year survival (62.0% vs. 22.0%; p=0.004) compared with patients treated with medications. Researchers also observed that by subdividing the participants into groups with valve replacement with and without PH and without valve replacement with and without PH, survival was higher in the group with valve replacement and without PH, followed by those with valve replacement and PH, without valve replacement and without PH; and finally, without valve replacement and with PH (p<0.0001). This indicates that even with increased risk of mortality, patients with high SPAP should also be referred for surgery because the outcome is better than just conservative treatment.
Although PH increases morbidity and mortality in cardiac surgery, only four out of 19 risk stratification models consider PH a risk factor for these surgeries 26 . A recent study evaluated the accuracy of the STS risk stratification model for 3 343 patients with PH undergoing the most common cardiac surgeries, of which 24.9% were aortic valve replacement surgery. Researchers found that mortality was significantly higher than predicted by the STS score for moderate and severe PH patients and suggested the inclusion of the variable PH in the risk score model studied 27 .
The current American 11 and European 12 guidelines for the management of valvular heart disease use the presence of PH to decide the moment of intervention in patients with mitral valve disease, but the same does not happen in the aortic valve disease. However, as found in this study and in other studied presented here, it is believed that PH should be considered when discussing the best time for surgery in patients with aortic valve disease, knowing that, when present, moderate to severe PH has a major impact on the survival of patients.
Conclusion
The patients who underwent aortic valve replacement surgery with moderate to severe PH had higher surgical mortality and worse three-year survival.
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